Brief Communication | Published:

Male-pattern baldness susceptibility locus at 20p11

Nature Genetics 40, 1282–1284 (2008) | Download Citation

Subjects

Abstract

We conducted a genome-wide association study for androgenic alopecia in 1,125 men and identified a newly associated locus at chromosome 20p11.22, confirmed in three independent cohorts (n = 1,650; OR = 1.60, P = 1.1 × 10−14 for rs1160312). The one man in seven who harbors risk alleles at both 20p11.22 and AR (encoding the androgen receptor) has a sevenfold-increased odds of androgenic alopecia (OR = 7.12, P = 3.7 × 10−15).

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

References

  1. 1.

    Disorders of hair growth: Diagnosis and Treatment 257 (McGraw-Hill, New York, 1994).

  2. 2.

    , & J. Am. Acad. Dermatol. 29, 568–575 (1993).

  3. 3.

    et al. J. Clin. Endocrinol. Metab. 91, 1357–1363 (2006).

  4. 4.

    , , & J. Invest. Dermatol. 121, 1561–1564 (2003).

  5. 5.

    , & J. Invest. Dermatol. 116, 452–455 (2001).

  6. 6.

    et al. Cancer Epidemiol. Biomarkers Prev. 14, 993–996 (2005).

  7. 7.

    et al. Am. J. Hum. Genet. 77, 140–148 (2005).

  8. 8.

    , , & Eur. J. Dermatol. 15, 339–340 (2005).

  9. 9.

    et al. J. Invest. Dermatol. 128, 2268–2270 (2008).

  10. 10.

    et al. Lancet 371, 483–491 (2008).

  11. 11.

    & Am. J. Hum. Genet. 76, 8–32 (2005).

  12. 12.

    & Ann. Epidemiol. 15, 771–772 (2005).

  13. 13.

    & Nat. Med. 1, 705–706 (1995).

  14. 14.

    , & Nat. Biotechnol. 18, 420–423 (2000).

Download references

Acknowledgements

We wish to acknowledge the cooperation and dedication of the study participants and the personnel at the recruitment centers and core facilities. We would like to acknowledge the genotyping contributions of D. Smyth and J. Todd. This study was funded in part by GlaxoSmithKline; deCODE Genetics; the Wellcome Trust; NIHR Biomedical Research Centre (grant to Guys' and St. Thomas' Hospitals and King's College London); the Chronic Disease Research Foundation; the Canadian Institutes of Health Research (J.B.R.) and the Sixth Framework Program of the EU contract number 018827 (Polygene).

Author information

    • Tim D Spector
    •  & Vincent Mooser

    These authors contributed equally to this work.

Affiliations

  1. Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK.

    • J Brent Richards
    • , Veronique Bataille
    • , Daniel Glass
    • , Nicole Soranzo
    •  & Tim D Spector

  2. Department of Medicine, Jewish General Hospital, Faculty of Medicine, McGill University, Montréal, Québec H3T 1E2, Canada.

    • J Brent Richards

  3. Genetics Division, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, USA.

    • Xin Yuan
    • , Dawn Waterworth
    • , Kijoung Song
    •  & Vincent Mooser

  4. deCODE Genetics, Reykjavik 101, Iceland.

    • Frank Geller
    • , Bragi Walters
    • , Unnur Thorsteinsdottir
    • , Augustine Kong
    • , Thorunn Rafnar
    • , Patrick Sulem
    • , Hreinn Stefansson
    •  & Kari Stefansson

  5. Department of Internal Medicine, CHUV University Hospital, Lausanne 1011, Switzerland.

    • Gerard Waeber
    •  & Peter Vollenweider

  6. Comprehensive Cancer Center IKO, Radboud University Nijmegen Medical Center, Nijmegen 6501 BG, The Netherlands.

    • Katja K H Aben

  7. Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Center, Nijmegen 6500 HB, The Netherlands.

    • Katja K H Aben

  8. Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Center, Nijmegen 6500 HB, The Netherlands.

    • Lambertus A Kiemeney

  9. Department of Urology, Radboud University Nijmegen Medical Center, Nijmegen 6525 GA, The Netherlands.

    • Lambertus A Kiemeney

  10. Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK.

    • Nicole Soranzo
    •  & Panos Deloukas

Authors

  1. Search for J Brent Richards in:

  2. Search for Xin Yuan in:

  3. Search for Frank Geller in:

  4. Search for Dawn Waterworth in:

  5. Search for Veronique Bataille in:

  6. Search for Daniel Glass in:

  7. Search for Kijoung Song in:

  8. Search for Gerard Waeber in:

  9. Search for Peter Vollenweider in:

  10. Search for Katja K H Aben in:

  11. Search for Lambertus A Kiemeney in:

  12. Search for Bragi Walters in:

  13. Search for Nicole Soranzo in:

  14. Search for Unnur Thorsteinsdottir in:

  15. Search for Augustine Kong in:

  16. Search for Thorunn Rafnar in:

  17. Search for Panos Deloukas in:

  18. Search for Patrick Sulem in:

  19. Search for Hreinn Stefansson in:

  20. Search for Kari Stefansson in:

  21. Search for Tim D Spector in:

  22. Search for Vincent Mooser in:

Contributions

V.M., P.V., G.W. and D.W. designed and implemented the CoLaus Study and the primary nested male-pattern baldness study. J.B.R., F.G., L.A.K., H.S., K. Stefansson, T.D.S. and V.M. designed the final study with appropriate replication datasets. J.B.R., X.Y., F.G., D.W., K. Song and V.M. analyzed the data. J.B.R., V.B., D.G., G.W., P.V., D.W., K.K.H.A., L.A.K., B.W., U.T., A.K., T.R., P.S., T.D.S. and V.M. contributed to data collection and phenotype definitions. V.B., G.W., T.D.S. and V.M. obtained funding. N.S. and P.D. performed genotyping for the women from the TwinsUK cohort. J.B.R. wrote the first draft of the paper and all authors made important contributions to the final version of the paper.

Competing interests

Xin Yuan, Dawn Waterworth, Kijoung Song and Vincent Mooser are full-time employees of GlaxoSmithKline. Peter Vollenweider and Gérard Waeber received financial support from GlaxoSmithKline to build the CoLaus study. Frank Geller, Bragi Walters, Unnur Thorsteinsdottir, Augustine Kong, Thorunn Rafnar, Patrick Sulem, Hrein Stefansson and Kari Stefansson are full-time employees of deCODE genetics.

Corresponding author

Correspondence to Tim D Spector.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Methods and Supplementary Figures 1 and 2

To obtain permission to re-use content from this article visit RightsLink.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ng.255

Further reading Further reading